Sign in
4

Changes in Ownership

Taysha Gene Therapies, Inc. Filed Acc 0001793412-26-000002

CHIEF FINANCIAL OFFICER acquired 359,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Alam Kamran CHIEF FINANCIAL OFFICER 2026-01-12 Grant or award +359,000 1,546,603 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Alam Kamran CHIEF FINANCIAL OFFICER 2026-01-12 Grant or award · Employee Stock Option (right to buy) +231,000 231,000 D: show line 2 in the form
Loading xslF345X05/form4-01142026_040105.xml…